Found: 63
Select item for more details and to access through your institution.
WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1.
- Published in:
- Journal of Extracellular Vesicles, 2021, v. 10, n. 4, p. 1, doi. 10.1002/jev2.12067
- By:
- Publication type:
- Article
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01068-w
- By:
- Publication type:
- Article
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00993-0
- By:
- Publication type:
- Article
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00886-8
- By:
- Publication type:
- Article
Leptotrichia trevisanii Sepsis after Bone Marrow Transplantation.
- Published in:
- Emerging Infectious Diseases, 2013, v. 19, n. 10, p. 1690, doi. 10.3201/eid1910.121048
- By:
- Publication type:
- Article
Wharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 2, p. 196, doi. 10.3390/ph8020196
- By:
- Publication type:
- Article
Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia‐related changes: A single institution experience
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 4, p. 738, doi. 10.1111/ijlh.13840
- By:
- Publication type:
- Article
High‐level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 1, p. 99, doi. 10.1111/ijlh.13316
- By:
- Publication type:
- Article
Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature.
- Published in:
- 2009
- By:
- Publication type:
- journal article
EGFR as a potent CAR T target in triple negative breast cancer brain metastases.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 1, p. 57, doi. 10.1007/s10549-022-06783-1
- By:
- Publication type:
- Article
Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review Polina.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.138373
- By:
- Publication type:
- Article
"Waitlist mortality" is high for myeloma patients with limited access to BCMA therapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1206715
- By:
- Publication type:
- Article
Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1005031
- By:
- Publication type:
- Article
Efficacy and safety of idecabtagene vicleucel in patients with relapsed–refractory multiple myeloma not meeting the KarMMa‐1 trial eligibility criteria: A real‐world multicentre study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1293, doi. 10.1111/bjh.19302
- By:
- Publication type:
- Article
Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 2, p. 228, doi. 10.1177/1078155214560920
- By:
- Publication type:
- Article
Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2014, v. 20, n. 4, p. 263, doi. 10.1177/1078155213502103
- By:
- Publication type:
- Article
A novel hematopoietic progenitor cell mobilization regimen, utilizing bortezomib and filgrastim, for patients undergoing autologous transplant.
- Published in:
- Journal of Clinical Apheresis, 2016, v. 31, n. 6, p. 559, doi. 10.1002/jca.21449
- By:
- Publication type:
- Article
Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
- Published in:
- Journal of Clinical Apheresis, 2016, v. 31, n. 4, p. 347, doi. 10.1002/jca.21404
- By:
- Publication type:
- Article
Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 2, p. 481, doi. 10.1007/s00277-018-3532-1
- By:
- Publication type:
- Article
Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 5, p. 847, doi. 10.1007/s00277-013-1981-0
- By:
- Publication type:
- Article
Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT).
- Published in:
- 2013
- By:
- Publication type:
- Letter
Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.
- Published in:
- Lung, 2017, v. 195, n. 6, p. 781, doi. 10.1007/s00408-017-0051-0
- By:
- Publication type:
- Article
Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple Myeloma.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2938, doi. 10.3390/cancers16172938
- By:
- Publication type:
- Article
Clinical efficacy of retreatment of daratumumab‐based therapy (D2) in daratumumab‐refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 6, p. 626, doi. 10.1111/ejh.13942
- By:
- Publication type:
- Article
Neutralizing antibody responses against SARS‐CoV‐2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 458, doi. 10.1111/ejh.13826
- By:
- Publication type:
- Article
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple‐class relapsed/refractory multiple myeloma (RRMM).
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 6, p. 602, doi. 10.1111/ejh.13697
- By:
- Publication type:
- Article
Inpatient mortality of patients with multiple myeloma and renal impairment undergoing autologous stem cell transplantation.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 571, doi. 10.1111/ejh.13487
- By:
- Publication type:
- Article
Rates of complete diagnostic testing for patients with acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 4, p. 519, doi. 10.1002/cam4.406
- By:
- Publication type:
- Article
Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1152457
- By:
- Publication type:
- Article
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e344, doi. 10.1016/j.clml.2024.05.022
- By:
- Publication type:
- Article
Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. 178, doi. 10.1016/j.clml.2023.01.002
- By:
- Publication type:
- Article
Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 753, doi. 10.1016/j.clml.2022.05.004
- By:
- Publication type:
- Article
MM-313: Carfilzomib, Cyclophosphamide, and Dexamethasone (KCd) for the Treatment of Triple-Class Relapsed/Refractory Multiple Myeloma (RRMM): A Single-Institution Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S434, doi. 10.1016/S2152-2650(21)01969-8
- By:
- Publication type:
- Article
Poster: MM-313: Carfilzomib, Cyclophosphamide, and Dexamethasone (KCd) for the Treatment of Triple-Class Relapsed/Refractory Multiple Myeloma (RRMM): A Single-Institution Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S253, doi. 10.1016/S2152-2650(21)01583-4
- By:
- Publication type:
- Article
Outcomes of Daratumumab, Pomalidomide, and Dexamethasone, Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation, in Patients With Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Outcomes of VD-PACE With Immunomodulatory Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correlative Analyses of Cytokine Release Syndrome and Neurological Events in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S251, doi. 10.1016/j.clml.2019.07.158
- By:
- Publication type:
- Article
Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy CTL019 In Adult Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)—An Interim Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S373, doi. 10.1016/j.clml.2017.07.213
- By:
- Publication type:
- Article
The University of Kansas Cancer Center (KUCC), an NCI designated comprehensive cancer center.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01902-y
- By:
- Publication type:
- Article
Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Bendamustine Associated with Irreversible Ascending Paralysis.
- Published in:
- Case Reports in Hematology, 2013, p. 1, doi. 10.1155/2013/931519
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 542, doi. 10.1093/cid/ciae291
- By:
- Publication type:
- Article
Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.
- Published in:
- Transfusion, 2024, v. 64, n. 8, p. 1402, doi. 10.1111/trf.17909
- By:
- Publication type:
- Article
Preclinical and Phase I Results of Decitabine in Combination with Midostaurin ( PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 12, p. 1341, doi. 10.1002/phar.1316
- By:
- Publication type:
- Article
Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 42, doi. 10.1002/ajh.24575
- By:
- Publication type:
- Article
Functional characterization of NPM1–TYK2 fusion oncogene.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00246-4
- By:
- Publication type:
- Article